Semaglutide, a GLP-1 receptor agonist (RA), was associated with a significantly lower risk for adult-onset epilepsy in patients with diabetes than other glucose-lowering drugs (GLDs). Notably, this ...

The Delhi High Court allowed Dr. Reddy’s to manufacture semaglutide in India and export it internationally but barred domestic sales until March 2026, when Novo Nordisk’s secondary patent expires.

Trials see no cognitive benefit from semaglutide for Alzheimer's Modest improvement seen in about a quarter of measured biomarkers Safety and tolerability consistent with previous trials SAN DIEGO, ...

Standard workplace drug tests are unlikely to detect Ozempic, since semaglutide controlled substances. While routine urine tests usually don’t reveal Ozempic, specialized blood tests can detect the ...

Ozempic (semaglutide) is an injectable medication initially designed to manage type 2 diabetes. Over the past few years, its potential to aid weight loss has captured more public attention. When ...

THE Intellectual Property Office of the Philippines (Ipophl) has reported confiscating P29.2 billion worth of fake goods as of November. “The year is not yet over. We have [a few more weeks] to go, ...

Ozempic (semaglutide) helps people with type 2 diabetes lower their blood sugar if diet, exercise, and other diabetes medications haven’t worked. If you’ve just gotten a prescription for it, you might ...

If you miss a dose of your weight loss or type 2 diabetes GLP-1 medication, you may not feel any differently right away, says Cecilia Low Wang, MD, a professor of medicine and director of the Glucose ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Ozempic has gained popularity for its impact on weight ...